Gilead Sciences Stock Analysis (NASDAQ:GILD)
Gilead Sciences Analysis Video
View Gilead Sciences stock analysis video. This is our GILD analyst opinion covering the buy and sell arguments for GILD stock.
Gilead Sciences, Inc. Stock Rating (4.2/5)
Our Gilead Sciences stock opinion is based on fundamentals of the company. This Gilead Sciences stock analysis is based on latest Q3 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.
Should you buy GILD stock?
- The TTM operating margin was good at 60.8% for Gilead Sciences.
- Net margins came in at average 47.7% for Gilead Sciences over the last twelve months.
- The price to earnings multiple of 6 is attractive when compared with the industry average PE ratio of 21.9.
- The lower PS ratio 3 for GILD stock versus Medical-Biomed-Genetics industry average of 4.5 is a positive for the company.
- Gilead Sciences's return on invested capital of 51.9% is good.
- Gilead Sciences has a good Return On Equity (ROE) of 89.2%.
- The company has a good Free Cash Flow (FCF) margin of 55.1%.